Cargando…

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer

BACKGROUND: Extent of peritoneal metastases (PM) is among the most powerful prognostic factors for survival after cytoreductive surgery (CRS). This study aimed to compare the Peritoneal Cancer Index (PCI) and the Dutch region count as tools for staging PM of colorectal cancer. The Dutch region count...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verheij, F. S., Bakkers, C., van Eden, W. J., Aalbers, A. G. J., Nienhuijs, S. W., Jóźwiak, K., de Hingh, I. H. J. T., Kok, N. F. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709381/ https://www.ncbi.nlm.nih.gov/pubmed/32573969 http://dx.doi.org/10.1002/bjs5.50313

Ejemplares similares

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
por: Bakkers, C., et al.
Publicado: (2021)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study
por: Lurvink, Robin J., et al.
Publicado: (2022)

Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study
por: Lurvink, Robin J., et al.
Publicado: (2021)

The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023)

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
por: van't Erve, Iris, et al.
Publicado: (2021)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases
por: Simkens, Geert A., et al.
Publicado: (2018)

Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)

Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial
por: Bakkers, C., et al.
Publicado: (2023)

Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database
por: Rijken, Anouk, et al.
Publicado: (2022)

Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases
por: Klaver, Charlotte E. L., et al.
Publicado: (2017)

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)
por: Lurvink, Robin J., et al.
Publicado: (2021)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

Treatment of peritoneal metastases from colorectal cancer
por: März, Loreen, et al.
Publicado: (2015)

DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial
por: Engbersen, M. P., et al.
Publicado: (2021)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

Spectral photon-counting CT imaging of colorectal peritoneal metastases: initial experience in rats
por: Thivolet, Arnaud, et al.
Publicado: (2020)

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
por: Ubink, I., et al.
Publicado: (2019)

Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis
por: Ng, Jia Lin, et al.
Publicado: (2016)

Outcomes of Combined Peritoneal and Local Treatment for Patients with Peritoneal and Limited Liver Metastases of Colorectal Origin: A Systematic Review and Meta-Analysis
por: Polderdijk, Margot C. E., et al.
Publicado: (2021)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer
por: Kastelein, Arnoud W., et al.
Publicado: (2020)

Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study
por: Yoshida, Shinya, et al.
Publicado: (2023)

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study
por: Mahteme, H, et al.
Publicado: (2004)

The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries
por: Ravn, Sissel, et al.
Publicado: (2020)

A population‐based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer
por: de Boer, Nadine L., et al.
Publicado: (2020)

Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial
por: Bastiaenen, Vivian P., et al.
Publicado: (2019)

The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
por: Rijken, Anouk, et al.
Publicado: (2021)

Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management
por: Sommariva, Antonio, et al.
Publicado: (2022)

Peritoneal Metastases
por: Yonemura, Yutaka, et al.
Publicado: (2012)

Colorectal peritoneal metastases: Optimal management review
por: Sánchez-Hidalgo, Juan Manuel, et al.
Publicado: (2019)

Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery
por: Chen, Chao, et al.
Publicado: (2020)

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023)

Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study
por: Rijken, Anouk, et al.
Publicado: (2023)

Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model
por: Wintjens, Anne G. W. E., et al.
Publicado: (2023)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hv7qcv2e2dibt8bb7tcesg3asj